Abstract:As a promising substitute for antibiotics, increasing attention has been given to the clinical application of antimicrobial peptides (AMPs). In this study, the mode of action of the HJH-3 against Salmonella Pullorum was investigated. The structure and properties of HJH-3 were examined in silico, and minimum inhibitory concentrations (MICs) were determined to evaluate its antimicrobial spectrum. The time-kill kinetics of HJH-3 was determined. The hemolytic activity of HJH-3 was determined by measuring the hemoglobin ultraviolet absorption value, and the cytotoxicity was determined using a CCK-8 kit. The protective effect of HJH-3 on chickens infected with S. Pullorum was evaluated in vivo. The results demonstrated that HJH-3 exhibited strong antibacterial activity against Gram-negative pathogens at MIC values of 1.5625-25 μg/mL and against Gram-positive pathogens at MIC values of 25-50 μg/mL. HJH-3 also showed activity against the Candida albicans (100 μg/mL) and Bacillus subtilis (6.25-12.5 μg/mL). HJH-3 at 100 μg/mL completely killed S. Pullorum after co-incubation for 6 h. Likewise, the hemolysis rate of CRBCs treated with 100 μg/mL HJH-3 (7.31%) was lower than that of CRBCs treated with 100 μg/mL pexiganan (40.43%). Although the hemolysis rate of CRBCs treated with 400 μg/mL HJH-3 was increased to 13.37%, it was much lower than that of 400 μg/mL pexiganan (57.27%). In regards to cytotoxicity, HJH-3 had almost no-effect on the CEF proliferation, pexiganan decreased CEFs proliferation from 56.93 to 31.00% when increasing the concentration from 50 to 200 μg/mL. In a chicken infection model, the results showed that the antibiotic prevention and HJH-3 prevention groups exhibited the best treatment effect, with the chickens being protected from the lethal dose of S. Pullorum, a decreased number of bacteria in the blood and spleen, and less pathological changes in intestinal segments. The prevention of infection by HJH-3 was similar to that by Ampicillin; the effect of treatment after infection was lower than that of treatment before infection, and the survival rate of infected chicks treated with HJH-3 was 70%, which was still higher than that of the infected chickens. These results suggest that HJH-3 has good clinical application potential and can be used as a substitute for antibiotics for the prevention and treatment of S. Pullorum infection.

Evaluation of therapeutic efficacy of antimicrobial peptide JH-3 in Salmonella infection

Evaluation of therapeutic efficacy of antimicrobial peptide JH-3 in Salmonella infection

Antimicrobial Peptide JH-3 Effectively Kills Salmonella enterica Serovar Typhimurium Strain CVCC541 and Reduces Its Pathogenicity in Mice

Inhibitory Effects of Antimicrobial Peptide JH-3 on Salmonella enterica Serovar Typhimurium Strain CVCC541 Infection-Induced Inflammatory Cytokine Release and Apoptosis in RAW264.7 Cells

Lacticaseibacillus Rhamnosus Alleviates Intestinal Inflammation and Promotes Microbiota-Mediated Protection Against Salmonella Fatal Infections.

Cytoprotective Effects of <i>Lactobacilli</i> on Mouse Epithelial Cells during <i>Salmonella</i> Infection

Evaluation of the efficacy of the antimicrobial peptide HJH-3 in chickens infected with Salmonella Pullorum

Transcriptomic and Proteomic Analysis of the Jejunum Revealed the Effects and Mechanism of Protocatechuic Acid on Alleviating Salmonella Typhimurium Infection in Chickens

Intracellular mechanism of antimicrobial peptide HJH-3 against Salmonella pullorum

The Antimicrobial Peptide Cathelicidin-Bf Could Be A Potential Therapeutic for Salmonella Typhimurium Infection

Identification of the natural product paeonol derived from peony bark as an inhibitor of the Salmonella enterica serovar Typhimurium type III secretion system

Bioactive Triple Peptide Inhibits Inflammasome Activation to Alleviate Salmonella-induced Intestinal Inflammation in Mice Via Modulation of Host Defense and Bacterial Virulence

Effects of a Novel Bacillus Subtilis GXYX Crude Lipopeptide Against Salmonella Enterica Serovar Typhimurium Infection in Mice

Lasso peptide MccY alleviates non-typhoidal salmonellae-induced mouse gut inflammation via regulation of intestinal barrier function and gut microbiota

Biochemical property and in vivo efficacies of novel Val/Arg-rich antimicrobial peptide.

The lasso peptide produced by Bacillus licheniformis MCC 2514 demonstrates efficacy in treating in-vivoSalmonella Typhimurium infection

The lasso peptide produced by Bacillus licheniformis MCC 2514 demonstrates efficacy in treating in-vivo Salmonella Typhimurium infection

Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model

Therapeutic Effect of Probiotic-Fermented Herbal Blend As Antibiotic Alternative on Salmonellosis by Multi-Drug Resistant Salmonella Pullorum

The Prophylactic Protection of Salmonella Typhimurium Infection by Lentilactobacillus Buchneri GX0328-6 in Mice

Designed Symmetrical Β-Hairpin Peptides for Treating Multidrug-Resistant Salmonella Typhimurium Infections.